Third dose of Pfizer’s COVID – 19 vaccine within 12 months of getting fully inoculated could most likely prolong protection : Pfizer’s CEO[1] Albert Bourla has recently made some speculations about Pfizer’s COVID–19 vaccine. He claimed that people might need a 3rd dose of the vaccine after getting fully inoculated. Per his claims, this is […]
Pfizer announces that it will supply its COVID – 19 vaccine to India only through government contracts : Recently there has been news about the Indian government regarding the procuration of vaccines from foreign companies. This is due to media reports which claim that the government is exploring options to allow private players to do
AstraZeneca’s diabetes drug Farxiga falls short in the global trial conducted to check its efficacy on COVID – 19 patients : On 12 April 2021, AstraZeneca announced the failure of its diabetes drug in treating hospitalized COVID – 19 patients. The drug that was tested using this trial is called Farxiga. The British drugmaker conducted
AstraZeneca yet to respond to EU’s letter on the material breach of contract over the vaccine supply in Europe : On 19 March 2021, EU[1] sent a letter to AstraZeneca to complain over the below–contract supplies of its COVID – 19 vaccine. However, the pharmaceutical company has failed to respond to this letter to date.
Pfizer seeks USFDA’s approval for using its COVID – 19 vaccine in adolescents aged 12 to 15 years old On 9 April 2021, Pfizer – BioNTech sought the USFDA[1] to authorization its COVID – 19 vaccine. This was for the use of the vaccine for 12 to 15 years old in the United States. Pfizer
Pfizer seeks USFDA’s approval for COVID vaccine in adolescents Read More »
Mankind Pharma expands its OTC portfolio by launching ‘Health OK’ tablets : Mankind Pharma has been actively expanding its OTC[1] range of products these days. Recently, this pharma company incorporated a new product called ‘Health OK’ tablets under its OTC portfolio. This is a multivitamin tablet and food supplement. The company claimed that ‘Health OK’
Zydus Cadila and Alembic Pharma initiate a nationwide recall of 2 drugs in the US following complaints : The US[1] health regulator, USFDA[2], has recently posted two separate announcements on its website. These announcements state the voluntary recall of some products by two major pharma firms in the US. The two pharma firms that have
Zydus and Alembic initiate a recall of 2 drugs in the US Read More »
Sun Pharma and Cadila, along with two other pharma firms, invest around Rs. 40 crore each in ABCD Technologies : Four drug majors have recently announced that they have subscribed to partnership interest in a healthcare services firm. The drug majors involved are Sun Pharma, Cadila Healthcare, Lupin, and Torrent Pharma. These companies have invested
Why Indian Pharma investing in IndoHealth Services? Read More »
Aleor Dermaceuticals, a joint venture of Alembic Pharma gets the USFDA approval for its generic antifungal cream : On 1 April 2021, Alembic Pharma made an announcement regarding its joint venture Aleor Dermaceuticals. It stated that the latter had received the USFDA’s[1] approval for a generic antifungal cream. This generic version contains Nystatin and Triamcinolone
Biocon Pharma and Libbs Farmaceutica collaborate to launch generic drugs in Brazil : Biocon Pharma is a wholly–owned subsidiary of Biocon. This pharma has recently entered into a partnership with Libbs Farmaceutica. The latter is a leading pharmaceutical company in Brazil. This partnership motive is to assist Biocon in the launch of generic drugs in
